Browsing: Limited

He missed four games due to injury. His Ravens failed to reach the playoffs. And for the first time in his career, Jackson logged fewer than 100 rushing attempts, finishing with 67 carries for 349 yards and two touchdowns.

Shares of Atour Lifestyle Holdings Limited Sponsored ADR (NASDAQ:ATAT – Get Free Report) have been assigned an average rating of “Moderate Buy” from the nine research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the…

Choroids Limited is a startup duly incorporated under the laws of Federal Republic of Nigeria. It is the developer of eSelfcare Mobile, the app for self-care with plants. eSelfcare Mobile is an app which provides users scientifically valid information on how to safely care for themselves, families, or friends using plants. It is an app for…

HealthDay News — For individuals with hip osteoarthritis, exercise produces small improvements in pain and physical function, but these improvements may not be clinically meaningful, according to a review published online July 22 in the Cochrane Database of Systematic Reviews

OLP CAPITAL MANAGEMENT Ltd trimmed its position in shares of Atour Lifestyle Holdings Limited Sponsored ADR (NASDAQ:ATAT – Free Report) by 6.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,109,037 shares of the company’s stock after selling 547,457 shares during the period.…

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market’s attention and deliver solid returns. But finding a great growth stock is not easy at all

ABN Amro Investment Solutions grew its stake in Atour Lifestyle Holdings Limited Sponsored ADR (NASDAQ:ATAT – Free Report) by 48.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 314,672 shares of the company’s stock after buying an additional 102,742 shares…

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

LONDON, July 10, 2026 /PRNewswire/ — Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX) today closed its previously announced exercise of certain outstanding preferred investment options to purchase up to an aggregate of 548,000 ordinary shares of the Company, par value $0.025 (the “Ordinary Shares”) originally issued in October 2023 (as amended in December…